Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET
1. LTRN scheduled Q4 & Fiscal Year 2024 earnings call for upcoming date.
FAQ
Why Neutral?
Earnings calls typically have uncertain impacts; previous calls showed mixed results for LTRN.
How important is it?
Announcements related to earnings can shift sentiment but without prior data, the impact remains speculative.
Why Short Term?
The earnings call's relevance is immediate, influencing investor sentiment shortly before and after results are revealed.